ArticleJournal of multidisciplinary healthcare2026
Internet of Things-Enabled Pulmonary Rehabilitation for Advanced Lung Cancer Patients Receiving Chemotherapy: A Qualitative Study of Healthcare Professional and Patient Perspectives.
Article in Journal of multidisciplinary healthcare, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study aimed to explore healthcare professionals' and patients' perceptions and experiences of Internet of Things (IoT)-enabled pulmonary rehabilitation (PR) among advanced lung cancer patients undergoing chemotherapy, to provide evidence-based references for the development and optimization of standardized, targeted IoT-based PR intervention programs for this patient population. Methods: A qualitative descriptive design was adopted. Semi-structured one-on-one interviews were conducted with healthcare professionals and advanced lung cancer patients who received chemotherapy. The team discussion established the framework for a semi-structured interview focusing on the Restricted implementation, needs, vision, and implementation of IoT-enabled PR. All interview data were systematically collected, sorted, and analyzed thematically. Results: A total of 18 healthcare professionals and 15 advanced lung cancer chemotherapy patients were enrolled in this study. The results revealed that PR implementation for patients with advanced lung cancer was generally neglected in clinical practice. Both participant groups exhibited insufficient professional cognition, prevalent misconceptions about pulmonary rehabilitation, and a lack of unified, standardized operating procedures for the clinical application of IoT-PR. Participants universally emphasized that individualized IoT-PR schemes and sustained social support were core guarantees of effective rehabilitation. Additionally, most participants held positive attitudes toward IoT-enabled PR, recognizing its unique advantages in improving rehabilitation convenience and providing comprehensive, whole-course rehabilitation guidance for patients. Conclusion: Pulmonary rehabilitation for advanced lung cancer chemotherapy patients is currently underrecognized by both clinical staff and patients. The innovative IoT-enabled PR model integrates the hierarchical medical resources of tertiary hospitals, secondary hospitals, and community health institutions, enabling seamless integration of hospital- and home-based rehabilitation services, thereby complementing and expanding traditional offline PR modes. It is essential to strengthen professional publicity and education to improve cognition of IoT-PR, establish standardized and individualized rehabilitation protocols, and fully leverage the technical advantages of the IoT. These targeted improvements can effectively promote the standardized popularization and clinical application of PR in advanced lung cancer chemotherapy populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.